Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.
As Eli Lilly and Novo Nordisk scramble to bring an oral glucagon-like peptide 1 (GLP-1) receptor agonist to market for obesity, much smaller potential rival Structure Therapeutics spotlighted positive ...
Investor's Business Daily on MSN
Dow Jones futures rise; will AI rebound or drag down market? Tesla, Eli Lilly in buy areas
Bears mauled AI stocks, but the Dow Jones and Russell 2000 hit new highs last week. Tesla and Eli Lilly are in buy zones.
S&P 500 shows strong EPS growth, PEG 1.22x, 2.4%–2.5% equity risk premium, and strategists forecast mid-7000s by 2026. Learn ...
Discover 10 undervalued healthcare stocks and why pharmaceuticals and providers stand out for value and quality.
Cresco Labs rally sees stock surge 75% after analyst upgrades. Despite weak financials, optimism fuels the CRLBF jump.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback